Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Dec 21, 2025

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Intraventricular pseudolymphoma a case review.

Jayant Rajah¹, Sarah A Cain², Peter Mews¹

¹Department of Neurosurgery, The Canberra Hospital, Garran, ACT, Australia.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia

|May 18, 2020

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Posterior thoracic discectomy and interbody fusion for the correction of severe hyperkyphotic deformity: technical note and case report.

Journal of spine surgery (Hong Kong)·2026

Same author

Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.

Nature medicine·2025

Same author

Interspecific effects of invasive wild pigs (<i>Sus scrofa</i>) on native nine-banded armadillos (<i>Dasypus novemcinctus</i>).

Journal of mammalogy·2025

Same author

Surgical outcomes in diffuse leptomeningeal glioneuronal tumours: a systematic review and individual patient data meta-analysis.

Neurosurgical review·2025

Same author

A perioperative study of Safusidenib in patients with <i>IDH1</i>-mutated glioma.

Future oncology (London, England)·2024

Same author

Changing practice to improve quality of life in glioma.

Journal of neurosurgery·2024

Intracranial pseudolymphoma is rare. A case of a 44-year-old female with a ventricular lesion revealed benign lymphoid tissue, marking the first intraventricular and third overall reported instance.

Area of Science:

Neurology
Oncology
Pathology

Background:

Intracranial pseudolymphoma is an exceptionally rare condition.
A history of Burkitt's lymphoma preceded the current presentation.

Observation:

A 44-year-old female presented with headaches.
Imaging revealed a right lateral ventricular lesion in a patient with a history of Burkitt's lymphoma.

Findings:

Biopsy confirmed the lesion was benign reactive lymphoid tissue, not malignant lymphoma.
This represents the third reported case of intracranial pseudolymphoma and the first intraventricular occurrence.

Implications:

This case underscores the importance of considering benign mimics in the differential diagnosis of intracranial lesions, especially in patients with a history of lymphoma.

Keywords:

Intracranial pseudolymphoma Intraventricular Lymphoma

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Related Experiment Videos

Last Updated: Dec 21, 2025

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Accurate histopathological diagnosis is essential to avoid unnecessary aggressive treatment for lymphoma.